Cargando…
Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition
Autores principales: | Dewan, Anna K., Gupta, Sameer, Bach, Daniel Q., Jadeja, Saagar, Granter, Scott, LaCasce, Ann, Joyce, Robin, Davids, Matthew S., Huang, Victor, LeBoeuf, Nicole R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479163/ https://www.ncbi.nlm.nih.gov/pubmed/31049381 http://dx.doi.org/10.1016/j.jdcr.2018.03.005 |
Ejemplares similares
-
Delayed-onset psoriasiform eruption secondary to a phosphoinositide 3-kinase inhibitor: A case report and literature review
por: Tran, Duy C., et al.
Publicado: (2022) -
Nonbullous pemphigoid secondary to PD-1 inhibition
por: Singer, Sean, et al.
Publicado: (2019) -
Psoriasiform Eruption Secondary to PI3K-delta Inhibitor: Expanding the Spectrum of Psoriasiform Paradoxical Reactions?
por: PESQUÉ, David, et al.
Publicado: (2021) -
Psoriasiform Drug Eruption Associated with Sodium Valproate
por: Gul Mert, Gulen, et al.
Publicado: (2013) -
Cyclosporine for refractory Kawasaki disease with psoriasiform eruption
por: Leyendecker, Mara, et al.
Publicado: (2021)